New antibody shot shields vulnerable patients from COVID-19
NCT ID NCT07473986
First seen Apr 06, 2026 · Last updated May 22, 2026 · Updated 10 times
Summary
This study looked at whether a medicine called Evusheld could help prevent COVID-19 in people with weakened immune systems who did not get protection from vaccines. 88 adults who had not made antibodies after vaccination took part. The goal was to see how many got sick with COVID-19 symptoms. Evusheld is a shot of lab-made antibodies that may give up to 12 months of protection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 OMICRON VARIANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Pavia, 27100, Italy
Conditions
Explore the condition pages connected to this study.